Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.44 |
| ▸ | AR | P10275 | 2/20 | 0.38 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.38 |
| ▸ | ALK | Q9UM73 | 7/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | USP8 | P40818 | 1/20 | 0.35 |
| ▸ | USP7 | Q93009 | 1/20 | 0.35 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.35 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.35 |
| ▸ | ITK | Q08881 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18907177 | 0.92 | PDK2 (0.52) | ALDH1A1CYP2A6PDK2ARMALT1 | |
| SCHEMBL13074415 | 0.88 | PDK2 (0.51) | ALDH1A1CYP2A6PDK2MALT1KDM1A | |
| SCHEMBL31025678 | 0.88 | PDK2 (0.51) | ALDH1A1CYP2A6PDK2MALT1KDM1A | |
| SCHEMBL18907195 | 0.87 | ALDH1A1 (0.47) | ALDH1A1CYP2A6PDK2MALT1ALK | |
| SCHEMBL18907228 | 0.87 | PDK2 (0.44) | ALDH1A1CYP2A6PDK2ARMALT1 | |
| SCHEMBL30882466 | 0.86 | PDK2 (0.45) | ALDH1A1CYP2A6PDK2ARMALT1 | |
| SCHEMBL15728990 | 0.82 | ALDH1A1 (0.43) | ALDH1A1CYP2A6PDK2ARMALT1 | |
| SCHEMBL19286810 | 0.82 | PDK2 (0.47) | ALDH1A1CYP2A6PDK2 | |
| SCHEMBL26224741 | 0.81 | PDK2 (0.40) | ALDH1A1CYP2A6PDK2ALK | |
| SCHEMBL23624452 | 0.80 | ALDH1A1 (0.42) | ALDH1A1CYP2A6PDK2ALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9328097-B2 | Thermally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2016-05-03 | — | — | US | disclosed |
| US-20150280138-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL, A METHOD OF SYNTHESIZING THE SAME AND AN OLED DEVICE USING THE SAME | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2015-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150280138-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL, A METHOD OF SYNTHESIZING THE SAME AND AN OLED DEVICE USING THE SAME | OCIAD1, OCIAD2, NOM1 | ALDH1A1 414/4885CYP2A6 3806/4885PDK2 3164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.